Treatment of Chronic Bacterial Prostatitis Caused by Enterococcus faecalis
Levofloxacin 500 mg orally once daily for 28 days is the recommended first-line treatment for chronic bacterial prostatitis caused by Enterococcus faecalis. 1
First-Line Treatment Options
- Levofloxacin 500 mg orally once daily for 28 days is FDA-approved specifically for chronic bacterial prostatitis due to Enterococcus faecalis and has demonstrated high microbiological eradication rates 1
- Fluoroquinolones (particularly levofloxacin) show low resistance rates against E. faecalis strains causing chronic bacterial prostatitis in clinical studies, making them suitable therapeutic agents 2
- The European Association of Urology guidelines recognize fluoroquinolones as effective agents for treating bacterial prostatitis 3
Alternative Treatment Options (for fluoroquinolone-resistant or intolerant patients)
Fosfomycin 3g orally every 24 hours for 1 week followed by 3g every 48 hours for a total of 6-12 weeks (consider longer duration if prostatic calcifications are present) 4
- Particularly effective against multidrug-resistant strains
- Achieves high microbiological eradication rates (86% at end of treatment)
- Clinical cure rates of 82% at end of treatment and 73% at 6 months 4
Ampicillin or amoxicillin (if susceptible):
Linezolid 600 mg IV or orally every 12 hours (duration dependent on clinical response) 3
- Recommended for enterococcal infections with strong evidence 3
Diagnostic Considerations
- Perform the Meares and Stamey 2- or 4-glass test to confirm chronic bacterial prostatitis and identify the causative pathogen 3
- Obtain expressed prostatic secretions (EPS) or post-prostatic massage urine (VB3) for culture and susceptibility testing 1, 2
- Consider transrectal ultrasound in selected cases to rule out prostatic abscess 3
Treatment Duration and Monitoring
- Standard treatment duration for chronic bacterial prostatitis is 4-6 weeks to ensure complete eradication 5, 6
- For complicated cases or those with prostatic calcifications, consider extending treatment to 12 weeks 4
- Monitor for clinical response (improvement in symptoms) and obtain follow-up cultures to confirm microbiological eradication 4
Special Considerations
- Resistance patterns of E. faecalis in chronic bacterial prostatitis show high resistance to tetracycline (97.5%), erythromycin (95%), and trimethoprim/sulfamethoxazole (31.5%), making these agents unsuitable as empiric therapy 2
- For multidrug-resistant E. faecalis, consider combination therapy or consultation with an infectious disease specialist 3
- Avoid aminoglycosides as monotherapy due to variable resistance patterns and poor prostatic penetration 7
Common Pitfalls and Caveats
- Inadequate treatment duration is a common cause of treatment failure and relapse; ensure a minimum of 4 weeks of therapy 5, 6
- Poor penetration of antibiotics into the prostate is a significant challenge; choose agents with favorable pharmacokinetic properties (lipid solubility, appropriate pKa) 7
- Distinguishing between bacterial prostatitis and non-bacterial prostatitis/prostatodynia is crucial as antimicrobial therapy is ineffective for non-bacterial forms 6
- Fluoroquinolone resistance is increasing globally; always obtain susceptibility testing to guide therapy 2, 5